You searched for "papillomatosis"
HPV – why equitable protection matters
Human papillomavirus (HPV) is one of the most common viruses in the world, with most people acquiring it during adolescence or early adulthood, often without ever knowing it [1]. HPV lives in the skin and the mucosal linings of the...
Handbook of Otolaryngology, Head and Neck Surgery – Second Edition
The authors and contributors of this book have done a stellar job of updating the content while maintaining the portability essential for any ‘handbook’. They begin with a sound introductory section which presents a comprehensive road map to evaluating the...
Risk of second primary cancer among patients with head and neck cancers
Patients with head and neck squamous cell carcinoma (HNSCC) have an elevated risk of developing a second primary malignant neoplasm (SPMN). These are of increasing concern because the number of survivors of HNSCC has been growing owing to early detection...
Dysphagia in people with HPV-related oropharyngeal cancer
Human papilloma virus (HPV) associated oropharyngeal cancers are becoming much more prevalent and, in some geographic areas, have overtaken tobacco as the leading cause of oropharyngeal cancer. HPV-associated cancers are also reported to have better prognosis in general, and research...
Extranodal extension following surgical resection of HPV-positive oropharyngeal cancer – is adjuvant radiotherapy alone sufficient?
Human papillomavirus (HPV) is a known aetiological factor in oropharyngeal squamous cell carcinoma (OPSCC). HPV-positive OPSCC is recognised to have a more favourable prognosis than HPV-negative disease. Treatment deintensification for HPV+ OPSCC has therefore been an area of research focus...OBITUARY: Throat Cancer Foundation CEO Jamie Rae
The Throat Cancer Foundation announces with deep sorrow the passing of its Chief Executive Officer, Jamie Rae, who passed away peacefully surrounded by his family and loved ones on 5 May 2025. Jamie Rae was not only the founder and...
Eosinophilic complications during dupilumab therapy
Dupilumab is a humanised monoclonal antibody that targets type 2 inflammation by blocking IL-4 and IL-13 signalling. Reported adverse events from its use include injection site erythema, conjunctivitis, arthralgia and hypereosinophilia. The potential for more severe eosinophilic-related complications such as...German Society Annual Congress DGHNO-KHC 2024
The 95th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC) was a great success under the forward-looking motto ‘Crossing Borders’Recalcitrant chronic rhinosinusitis: What to do next?
Whilst the majority of patients with chronic rhinosinusitis (CRS) will significantly improve with treatment, we are sometimes left with a ‘hard-core’ of nasal cripples who fail to improve despite our best efforts. How can we deal with these patients? Valerie...In conversation with Trevor McGill
After more than four decades of paediatric clinical practice, Trevor McGill shares his wealth of experience and knowledge with Pat Bradley. Trevor, as a national and internationally acknowledged Paediatric Oto-Rhino-Laryngologist, Head and Neck Surgeon, to what do you owe this...
